This template is within the scope of , a collaborative effort to improve the coverage of WikiProject Pharmacology Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
NA This template does not require a rating on the project's quality scale.
TfD debate [ edit ]
This template survived a discussion at
TfD. Several editors said it should be 'flattened' in some way. The debate can be found here. - Splash 19:46, 20 November 2005 (UTC)
Done. -- Arcadian 19:23, 1 January 2006 (UTC)
viricides be added to this template? -- stillnotelf 02:00, 1 February 2006 (UTC)
has a talk page
I'm not sure, but I'd reckon not. This template seems to be for drugs taken internally. Perhaps ask Ben.c.roberts, the user who originated it ..? Best wishes, David Kernow 18:11, 1 February 2006 (UTC)
I also tend towards no, I just thought it should be brought up. -- stillnotelf 23:28, 1 February 2006 (UTC) has a talk page
I propose this template be split into HIV and non-HIV antivirals. It's getting very big.
User:Hopping 04:09, 30 November 2007 (UTC)
You can see what I created at Template:HIVpharm. User:Hopping 22:26, 3 December 2007 (UTC)
T I think that's a pretty good idea. Fvasconcellos ( 22:39, 3 December 2007 (UTC) t· c) NOV-002 is currently in Phase III under Fast Track Special Protocol Assessment.
why are you saying Never to Phase III?
Fully enrolled Phase III trial link supplied.
Bixbyte ( talk) 16:27, 24 October 2009 (UTC)Bixbyte